跳至主要内容
临床试验/NCT00288288
NCT00288288已完成不适用

Prospective Registry of Epicardial LV Leads Placed During Cardiac Surgery Procedures

University of Kansas1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2006年3月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
40
试验地点
1

研究概览

简要总结

The primary purpose of this study is to compare the time, risk and cost savings of 2 patient groups who receive FDA approved left ventricular pacing leads.

详细描述

The purpose of this study is to: a) examine the usefulness of placing an epicardial LV lead at the time of open chest surgery in patients who are likely to benefit from a CRT system following their surgery; b) compare differences between patients who receive LV leads using the transvenous approach and those patients who receive LV leads using the epicardial approach; and c) assess the cost effectiveness of placing the LV lead via the transvenous versus the epicardial approaches.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Left ventricular ejection fraction < or = 35%
  • QRS duration greater than or = to 120ms
  • NYHA Functional Class 3 or 4
  • Age > or = to 18 years

排除标准

  • No previous pacemaker or ICD implant
  • No permanent atrial fibrillation

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Loren Berenbom, MD

Principal Investigator

University of Kansas

研究点 (1)

Loading locations...

相似试验